A new clinical trial will screen for atrial fibrillation (AFib) using a blood pressure monitor with AFib detection technology ...
Kevan Shokat, PhD, a professor of Cellular and Molecular Pharmacology at UC San Francisco who discovered how to disable KRAS, ...
From Machu Picchu to Mount Everest, people who live at high altitudes process sugar better and are less likely to develop ...
A preliminary study led by UC San Francisco adds to growing evidence that reducing ultra-processed food may improve symptoms of depression. Published Sept. 23 in JAMA Psychiatry, the study, which is ...
How does your brain decide whether to hit “send” on a risky email or delete the draft? Two neighboring parts of it argue with ...
Invasive lobular carcinoma (ILC) is the second most common type of breast cancer but is challenging to detect because of how it spreads in breast tissue. ILC has been understudied compared to other ...
UC San Francisco researchers are weighing in on one of the biggest challenges in psychedelic science, arguing that clinical trials need more convincing placebo treatments to better measure the drugs’ ...
Louise Walter, MD, chair of UCSF Geriatrics, served as vice-chair of the National Comprehensive Cancer Network (NCCN) Guidelines Panel for Older Adult Oncology, which recently new treatment guidelines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results